Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.

Liu C, Yang Z, Wang L, Lu Y, Tang B, Miao H, Xu Q, Chen X

Open source

DOI
10.1186/s12876-015-0380-5
Published
2015 Nov 16
Container
BMC gastroenterology
Publisher
Not recorded
Open access
yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.1186/s12876-015-0380-5,
  title = {Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.},
  author = {Liu C and Yang Z and Wang L and Lu Y and Tang B and Miao H and Xu Q and Chen X},
  year = {2015},
  journal = {BMC gastroenterology},
  doi = {10.1186/s12876-015-0380-5},
  url = {https://doi.org/10.1186/s12876-015-0380-5}
}

RIS

TY  - JOUR
TI  - Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.
AU  - Liu C
AU  - Yang Z
AU  - Wang L
AU  - Lu Y
AU  - Tang B
AU  - Miao H
AU  - Xu Q
AU  - Chen X
PY  - 2015
JO  - BMC gastroenterology
DO  - 10.1186/s12876-015-0380-5
UR  - https://doi.org/10.1186/s12876-015-0380-5
ER  - 

APA

C, L., Z, Y., L, W., Y, L., B, T., H, M., Q, X., & X, C. (2015). Combination of sorafenib and gadolinium chloride (GdCl3) attenuates dimethylnitrosamine(DMN)-induced liver fibrosis in rats.. BMC gastroenterology. https://doi.org/10.1186/s12876-015-0380-5

Source records